… a supplemental biologics license application for a 12-week dosing schedule of Eylea injection in wet age-related macular degeneration patients.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *